Drugs / iNKT cells
iNKT cells
Trials 7 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 12 trials | ||||||
| Phase 1 | NCT07713290 | Apr 2025 → Nov 2026 expected | hepatocellular carcinoma | Beijing Gene Key Life Technology Co., Ltd | Active not recruiting | No outcome recorded |
| Phase 1 | NCT03175679 | Apr 2017 → Dec 2018 | hepatocellular carcinoma | Beijing YouAn Hospital | Completed | No outcome recorded |
| Phase 1/22 trials | ||||||
| Phase 1/2 | NCT03551795 | Jan 2018 → Dec 2021 | cancer | Xiaoyan Zhang | Completed | No outcome recorded |
| Phase 1/2 | NCT03093688 | Mar 2017 → Dec 2030 expected | gastric cancer, hepatocellular carcinoma, malignant pancreatic neoplasm, non-small cell lung carcinoma +2 | Shanghai Public Health Clinical Center | Recruiting | No outcome recorded |
| Phase 23 trials | ||||||
| Phase 2 | NCT07209813 | Oct 2025 → Oct 2026 expected | hepatocellular carcinoma | Beijing Gene Key Life Technology Co., Ltd | Not yet recruiting | No outcome recorded |
| Phase 2 | NCT05962450 | Oct 2023 → Aug 2025 | hepatocellular carcinoma | Beijing YouAn Hospital | Unknown | No outcome recorded |
| Phase 2 | NCT04011033 | Mar 2018 → Mar 2020 | hepatocellular carcinoma | Beijing YouAn Hospital | Completed | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 7 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | iNKT cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03093688 ↗ |
| Known as | GKL-006 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07209813 ↗ |
| Known as | Invariant Natural killer T | “Invariant Natural killer T (iNKT) cells are a unique subset of lymphocytes” NCT03093688 ↗ |
| Action | Deplete | “Human iNKT cells can directly lysis tumor cells by a perforin-dependent mechanism” NCT03093688 ↗ |
| Modality | Cell therapy | “immunotherapy strategy of infusion of iNKT cells” NCT03551795 ↗ |
| Route | Intravenous | “through intravenous infusion” NCT03175679 ↗ |